289 related articles for article (PubMed ID: 15337618)
1. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
[TBL] [Abstract][Full Text] [Related]
2. An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients.
Sohmiya M; Tanaka M; Suzuki Y; Tanino Y; Okamoto K; Yamamoto Y
J Neurol Sci; 2005 Jan; 228(1):49-53. PubMed ID: 15607210
[TBL] [Abstract][Full Text] [Related]
3. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
J Clin Neurosci; 2007 Apr; 14(4):340-3. PubMed ID: 16647853
[TBL] [Abstract][Full Text] [Related]
4. Coenzyme Q10 changes are associated with metabolic syndrome.
Miles MV; Morrison JA; Horn PS; Tang PH; Pesce AJ
Clin Chim Acta; 2004 Jun; 344(1-2):173-9. PubMed ID: 15149886
[TBL] [Abstract][Full Text] [Related]
5. The coenzyme Q10 status of the brain regions of Parkinson's disease patients.
Hargreaves IP; Lane A; Sleiman PM
Neurosci Lett; 2008 Dec; 447(1):17-9. PubMed ID: 18840506
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults.
Miles MV; Horn PS; Tang PH; Morrison JA; Miles L; DeGrauw T; Pesce AJ
Clin Chim Acta; 2004 Sep; 347(1-2):139-44. PubMed ID: 15313151
[TBL] [Abstract][Full Text] [Related]
7. Serum cholesterol levels and the risk of Parkinson's disease.
de Lau LM; Koudstaal PJ; Hofman A; Breteler MM
Am J Epidemiol; 2006 Nov; 164(10):998-1002. PubMed ID: 16905642
[TBL] [Abstract][Full Text] [Related]
8. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.
Isobe C; Abe T; Terayama Y
Neurosci Lett; 2010 Jan; 469(1):159-63. PubMed ID: 19944739
[TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21.
Miles MV; Patterson BJ; Chalfonte-Evans ML; Horn PS; Hickey FJ; Schapiro MB; Steele PE; Tang PH; Hotze SL
Pediatr Neurol; 2007 Dec; 37(6):398-403. PubMed ID: 18021919
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
[TBL] [Abstract][Full Text] [Related]
11. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
Shults CW; Flint Beal M; Song D; Fontaine D
Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
[TBL] [Abstract][Full Text] [Related]
12. Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients.
Isobe C; Abe T; Terayama Y
Dement Geriatr Cogn Disord; 2009; 28(5):449-54. PubMed ID: 19907182
[TBL] [Abstract][Full Text] [Related]
13. Redox status of coenzyme Q10 is associated with chronological age.
Wada H; Goto H; Hagiwara S; Yamamoto Y
J Am Geriatr Soc; 2007 Jul; 55(7):1141-2. PubMed ID: 17608895
[No Abstract] [Full Text] [Related]
14. Peripheral blood markers of oxidative stress in Parkinson's disease.
Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa.
Agil A; Durán R; Barrero F; Morales B; Araúzo M; Alba F; Miranda MT; Prieto I; Ramírez M; Vives F
J Neurol Sci; 2006 Jan; 240(1-2):31-6. PubMed ID: 16219327
[TBL] [Abstract][Full Text] [Related]
16. Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q(10).
Lim SC; Tan HH; Goh SK; Subramaniam T; Sum CF; Tan IK; Lee BL; Ong CN
Diabet Med; 2006 Dec; 23(12):1344-9. PubMed ID: 17116186
[TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia.
Cordero MD; Moreno-Fernández AM; deMiguel M; Bonal P; Campa F; Jiménez-Jiménez LM; Ruiz-Losada A; Sánchez-Domínguez B; Sánchez Alcázar JA; Salviati L; Navas P
Clin Biochem; 2009 May; 42(7-8):732-5. PubMed ID: 19133251
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in newborn infants with and without asphyxia as measured by plasma antioxidants and free fatty acids.
Hara K; Yamashita S; Fujisawa A; Ishiwa S; Ogawa T; Yamamoto Y
Biochem Biophys Res Commun; 1999 Apr; 257(1):244-8. PubMed ID: 10092541
[TBL] [Abstract][Full Text] [Related]
20. [Platelet aggregation and coenzyme Q10 content in platelets in cancer patients].
Shinkai T; Tominaga K; Shimabukuro Z; Shimizu E; Eguchi K; Saijo N; Iwashita K; Niitani H
Gan To Kagaku Ryoho; 1984 Jan; 11(1):87-96. PubMed ID: 6230057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
